应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PLSE Pulse Biosciences, Inc.
交易中 03-31 13:04:35 EDT
21.10
+1.47
+7.46%
最高
21.44
最低
19.98
成交量
13.63万
今开
19.98
昨收
19.63
日振幅
7.41%
总市值
14.30亿
流通市值
3.68亿
总股本
6,777万
成交额
281.87万
换手率
0.78%
流通股本
1,744万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Pulse Biosciences启动Npulse™技术治疗恶性甲状腺肿瘤可行性研究首批患者入组
美股速递 · 03-12
Pulse Biosciences启动Npulse™技术治疗恶性甲状腺肿瘤可行性研究首批患者入组
Pulse Biosciences公布Npulse™ Vybrance™系统首次人体临床试验中良性甲状腺结节消融的持久性数据
美股速递 · 03-09
Pulse Biosciences公布Npulse™ Vybrance™系统首次人体临床试验中良性甲状腺结节消融的持久性数据
Pulse Biosciences获FDA批准,启动Npulse心脏导管消融系统针对房颤的研究
美股速递 · 2025-12-18
Pulse Biosciences获FDA批准,启动Npulse心脏导管消融系统针对房颤的研究
Pulse Biosciences, Inc. 宣布与 Npulse™ 技术合作开展良性及恶性甲状腺肿瘤治疗研究
美股速递 · 2025-12-09
Pulse Biosciences, Inc. 宣布与 Npulse™ 技术合作开展良性及恶性甲状腺肿瘤治疗研究
Pulse Biosciences 2025财年Q3业绩会总结及问答精华:初步商业化与临床进展
业绩会速递 · 2025-11-06
Pulse Biosciences 2025财年Q3业绩会总结及问答精华:初步商业化与临床进展
Pulse Biosciences第三季度运营亏损2036.7万美元
投资观察 · 2025-11-06
Pulse Biosciences第三季度运营亏损2036.7万美元
Pulse Biosciences Inc - Npulse心脏外科手术系统可行性研究中未报告重大不良事件
美股速递 · 2025-10-10
Pulse Biosciences Inc - Npulse心脏外科手术系统可行性研究中未报告重大不良事件
Pulse Biosciences宣布将在第39届欧洲心胸外科协会年会上发布其Npulse™心脏外科系统临床数据
美股速递 · 2025-10-07
Pulse Biosciences宣布将在第39届欧洲心胸外科协会年会上发布其Npulse™心脏外科系统临床数据
Pulse Biosciences, Inc盘中异动 大幅下跌5.15%报16.48美元
市场透视 · 2025-03-10
Pulse Biosciences, Inc盘中异动 大幅下跌5.15%报16.48美元
Pulse Biosciences, Inc盘中异动 快速跳水5.38%
市场透视 · 2025-03-06
Pulse Biosciences, Inc盘中异动 快速跳水5.38%
Pulse Biosciences, Inc盘中异动 股价大涨5.27%
市场透视 · 2025-02-26
Pulse Biosciences, Inc盘中异动 股价大涨5.27%
Pulse Biosciences, Inc盘中异动 股价大跌5.03%报20.79美元
市场透视 · 2025-02-20
Pulse Biosciences, Inc盘中异动 股价大跌5.03%报20.79美元
Pulse Biosciences, Inc盘中异动 股价大跌5.01%报21.24美元
市场透视 · 2025-02-12
Pulse Biosciences, Inc盘中异动 股价大跌5.01%报21.24美元
Pulse Biosciences, Inc盘中异动 大幅跳水5.00%报20.70美元
市场透视 · 2025-02-08
Pulse Biosciences, Inc盘中异动 大幅跳水5.00%报20.70美元
Pulse Biosciences, Inc盘中异动 早盘快速拉升5.02%报24.59美元
市场透视 · 2025-02-05
Pulse Biosciences, Inc盘中异动 早盘快速拉升5.02%报24.59美元
Pulse Biosciences, Inc盘中异动 大幅上涨5.93%报21.60美元
市场透视 · 2025-02-04
Pulse Biosciences, Inc盘中异动 大幅上涨5.93%报21.60美元
Pulse Biosciences, Inc盘中异动 早盘股价大涨5.19%报20.68美元
市场透视 · 2025-01-31
Pulse Biosciences, Inc盘中异动 早盘股价大涨5.19%报20.68美元
Pulse Biosciences, Inc盘中异动 下午盘大幅拉升5.01%
市场透视 · 2025-01-29
Pulse Biosciences, Inc盘中异动 下午盘大幅拉升5.01%
Pulse Biosciences, Inc盘中异动 股价大涨5.05%
市场透视 · 2025-01-25
Pulse Biosciences, Inc盘中异动 股价大涨5.05%
Pulse Biosciences, Inc盘中异动 股价大跌5.18%报17.75美元
市场透视 · 2025-01-24
Pulse Biosciences, Inc盘中异动 股价大跌5.18%报17.75美元
公司概况
公司名称:
Pulse Biosciences, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
脉冲生物科学有限公司最初于2014年5月19日在内华达州注册成立。自2018年6月18日起,该公司重新注册为特拉华州公司。该公司是一家新型消融公司,致力于利用其专利的纳米脉冲刺激(“NPS”)技术进行健康创新,这是一种革命性的能量模式,可提供纳秒级持续时间的电能脉冲,每次脉冲长度不到百万分之一秒,以非热方式清除或杀死靶细胞。NPS技术,也称为纳秒脉冲场消融(“nsPFA”)技术,当用于消融细胞组织时,可用于治疗各种尚未找到最佳解决方案的疾病。
发行价格:
--
{"stockData":{"symbol":"PLSE","market":"US","secType":"STK","nameCN":"Pulse Biosciences, Inc.","latestPrice":21.095,"timestamp":1774976670760,"preClose":19.63,"halted":0,"volume":136326,"delay":0,"changeRate":0.07463066734589913,"floatShares":17438312,"shares":67767578,"eps":-1.079911,"marketStatus":"交易中","change":1.465,"latestTime":"03-31 13:04:35 EDT","open":19.98,"high":21.435,"low":19.98,"amount":2818719.5913420003,"amplitude":0.074121,"askPrice":21.18,"askSize":14,"bidPrice":20.95,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.079911,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774987200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1463544000000,"exchange":"NASDAQ","adjPreClose":19.63,"preHourTrading":{"tag":"盘前","latestPrice":21.19,"preClose":19.63,"latestTime":"08:43 EDT","volume":40,"amount":847.40004,"timestamp":1774960996902,"change":1.56,"changeRate":0.07947,"amplitude":0.000509},"postHourTrading":{"tag":"盘后","latestPrice":19.66,"preClose":19.63,"latestTime":"19:04 EDT","volume":4505,"amount":88365.6601,"timestamp":1774911897936,"change":0.03,"changeRate":0.001528,"amplitude":0.013245},"volumeRatio":1.455282,"impliedVol":0.4365,"impliedVolPercentile":0.3267},"requestUrl":"/m/hq/s/PLSE/wiki","defaultTab":"wiki","newsList":[{"id":"1164341426","title":"Pulse Biosciences启动Npulse™技术治疗恶性甲状腺肿瘤可行性研究首批患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1164341426","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164341426?lang=zh_cn&edition=full","pubTime":"2026-03-12 19:03","pubTimestamp":1773313402,"startTime":"0","endTime":"0","summary":"生物科技公司Pulse Biosciences宣布,其采用Npulse™技术针对恶性甲状腺肿瘤治疗的可行性研究已完成首批患者入组。这项突破性进展标志着该创新疗法正式进入临床验证阶段,为甲状腺癌患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199241533","title":"Pulse Biosciences公布Npulse™ Vybrance™系统首次人体临床试验中良性甲状腺结节消融的持久性数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1199241533","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199241533?lang=zh_cn&edition=full","pubTime":"2026-03-09 19:02","pubTimestamp":1773054139,"startTime":"0","endTime":"0","summary":"Pulse Biosciences公司近日宣布,其Npulse™ Vybrance™系统在针对良性甲状腺结节消融的首次人体临床耐久性研究中取得了积极数据。该研究旨在评估该技术在治疗良性甲状腺结节方面的长期效果与安全性。\n研究结果显示,Npulse™ Vybrance™系统在消融良性甲状腺结节方面展现出显著的持久性,为患者提供了一种潜在的非侵入性治疗选择。这一进展标志着公司在医疗技术领域的创新突破,有望为甲状腺疾病治疗带来新的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141173874","title":"Pulse Biosciences获FDA批准,启动Npulse心脏导管消融系统针对房颤的研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1141173874","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141173874?lang=zh_cn&edition=full","pubTime":"2025-12-18 20:00","pubTimestamp":1766059215,"startTime":"0","endTime":"0","summary":"Pulse Biosciences获FDA批准,启动Npulse心脏导管消融系统针对房颤的研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183157749","title":"Pulse Biosciences, Inc. 宣布与 Npulse™ 技术合作开展良性及恶性甲状腺肿瘤治疗研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1183157749","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183157749?lang=zh_cn&edition=full","pubTime":"2025-12-09 20:02","pubTimestamp":1765281757,"startTime":"0","endTime":"0","summary":"Pulse Biosciences, Inc. 宣布与 Npulse™ 技术合作开展良性及恶性甲状腺肿瘤治疗研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100318354","title":"Pulse Biosciences 2025财年Q3业绩会总结及问答精华:初步商业化与临床进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1100318354","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100318354?lang=zh_cn&edition=full","pubTime":"2025-11-06 23:41","pubTimestamp":1762443664,"startTime":"0","endTime":"0","summary":"Pulse Biosciences管理层强调了其nPulse平台和Vibrance一次性产品在有限市场发布中的初步商业化采用。管理层确认,nPulse 360研究的资金将来自内部资源,主要在商业化阶段寻求战略合作伙伴。总收入为86,000美元,主要来自nPulse Capital和Vibrance一次性产品的初步销售。截至2025年9月30日,现金和现金等价物为9520万美元,而2024年9月30日为7900万美元。Pulse Biosciences在2025财年Q3取得了初步的商业化成功,并在临床试验方面取得了显著进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144910772","title":"Pulse Biosciences第三季度运营亏损2036.7万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144910772","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144910772?lang=zh_cn&edition=full","pubTime":"2025-11-06 05:26","pubTimestamp":1762377967,"startTime":"0","endTime":"0","summary":"11月5日(记者) - Pulse Biosciences第三季度净收入为负1938.5万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154288409","title":"Pulse Biosciences Inc - Npulse心脏外科手术系统可行性研究中未报告重大不良事件","url":"https://stock-news.laohu8.com/highlight/detail?id=1154288409","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154288409?lang=zh_cn&edition=full","pubTime":"2025-10-10 19:04","pubTimestamp":1760094267,"startTime":"0","endTime":"0","summary":"Pulse Biosciences Inc - Npulse心脏外科手术系统可行性研究中未报告重大不良事件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185898127","title":"Pulse Biosciences宣布将在第39届欧洲心胸外科协会年会上发布其Npulse™心脏外科系统临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1185898127","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185898127?lang=zh_cn&edition=full","pubTime":"2025-10-07 19:01","pubTimestamp":1759834884,"startTime":"0","endTime":"0","summary":"Pulse Biosciences宣布将在第39届欧洲心胸外科协会年会上发布其Npulse™心脏外科系统临床数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518275574","title":"Pulse Biosciences, Inc盘中异动 大幅下跌5.15%报16.48美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518275574?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:37","pubTimestamp":1741617435,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时37分,Pulse Biosciences, Inc股票出现异动,股价急速跳水5.15%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体跌幅为2.61%。Pulse Biosciences, Inc公司简介:Pulse Biosciences Inc .是一家新型生物医药公司,致力于利用其获得专利的纳米脉冲刺激技术进行健康创新,这是一种革命性的能量模式,可提供纳秒持续时间的电能脉冲,每个脉冲的长度小于百万分之一秒,以非热清除的目标细胞,同时不影响邻近的非细胞组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223715abf31526&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310223715abf31526&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517166003","title":"Pulse Biosciences, Inc盘中异动 快速跳水5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166003","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517166003?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:34","pubTimestamp":1741271657,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时34分,Pulse Biosciences, Inc股票出现异动,股价急速下跌5.38%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体跌幅为0.91%。其相关个股中,Sharps Technology Inc.、Anbio Biotechnology、哈佛生物科学涨幅较大,Sharps Technology Inc.、Bionano Genomics, Inc.、Glucotrack, Inc.较为活跃,换手率分别为26.36%、0.57%、0.46%,振幅较大的相关个股有中进医疗、Sharps Technology Inc.、Pulse Biosciences, Inc,振幅分别为8.95%、7.10%、4.39%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223417abeb787a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223417abeb787a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514564958","title":"Pulse Biosciences, Inc盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514564958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514564958?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:30","pubTimestamp":1740580256,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时30分,Pulse Biosciences, Inc股票出现波动,股价大幅拉升5.27%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体涨幅为0.00%。Pulse Biosciences, Inc公司简介:Pulse Biosciences Inc .是一家新型生物医药公司,致力于利用其获得专利的纳米脉冲刺激技术进行健康创新,这是一种革命性的能量模式,可提供纳秒持续时间的电能脉冲,每个脉冲的长度小于百万分之一秒,以非热清除的目标细胞,同时不影响邻近的非细胞组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223057a254f600&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223057a254f600&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512438269","title":"Pulse Biosciences, Inc盘中异动 股价大跌5.03%报20.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512438269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512438269?lang=zh_cn&edition=full","pubTime":"2025-02-20 02:12","pubTimestamp":1739988738,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日02时12分,Pulse Biosciences, Inc股票出现波动,股价快速下挫5.03%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体跌幅为0.02%。Pulse Biosciences, Inc公司简介:Pulse Biosciences Inc .是一家新型生物医药公司,致力于利用其获得专利的纳米脉冲刺激技术进行健康创新,这是一种革命性的能量模式,可提供纳秒持续时间的电能脉冲,每个脉冲的长度小于百万分之一秒,以非热清除的目标细胞,同时不影响邻近的非细胞组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220021218988b5511&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220021218988b5511&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510351199","title":"Pulse Biosciences, Inc盘中异动 股价大跌5.01%报21.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510351199","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510351199?lang=zh_cn&edition=full","pubTime":"2025-02-12 04:21","pubTimestamp":1739305319,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日04时21分,Pulse Biosciences, Inc股票出现异动,股价快速下挫5.01%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体涨幅为0.01%。Pulse Biosciences, Inc公司简介:Pulse Biosciences Inc .是一家新型生物医药公司,致力于利用其获得专利的纳米脉冲刺激技术进行健康创新,这是一种革命性的能量模式,可提供纳秒持续时间的电能脉冲,每个脉冲的长度小于百万分之一秒,以非热清除的目标细胞,同时不影响邻近的非细胞组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120421599881f4b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120421599881f4b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509729924","title":"Pulse Biosciences, Inc盘中异动 大幅跳水5.00%报20.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509729924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509729924?lang=zh_cn&edition=full","pubTime":"2025-02-08 01:06","pubTimestamp":1738947993,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日01时06分,Pulse Biosciences, Inc股票出现波动,股价快速下挫5.00%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体跌幅为0.42%。Pulse Biosciences, Inc公司简介:Pulse Biosciences Inc .是一家新型生物医药公司,致力于利用其获得专利的纳米脉冲刺激技术进行健康创新,这是一种革命性的能量模式,可提供纳秒持续时间的电能脉冲,每个脉冲的长度小于百万分之一秒,以非热清除的目标细胞,同时不影响邻近的非细胞组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208010633abc64c3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208010633abc64c3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509840235","title":"Pulse Biosciences, Inc盘中异动 早盘快速拉升5.02%报24.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509840235","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509840235?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:50","pubTimestamp":1738770657,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时50分,Pulse Biosciences, Inc股票出现波动,股价大幅拉升5.02%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体涨幅为1.04%。Pulse Biosciences, Inc公司简介:Pulse Biosciences Inc .是一家新型生物医药公司,致力于利用其获得专利的纳米脉冲刺激技术进行健康创新,这是一种革命性的能量模式,可提供纳秒持续时间的电能脉冲,每个脉冲的长度小于百万分之一秒,以非热清除的目标细胞,同时不影响邻近的非细胞组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205235057987b8ac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205235057987b8ac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508046885","title":"Pulse Biosciences, Inc盘中异动 大幅上涨5.93%报21.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508046885","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508046885?lang=zh_cn&edition=full","pubTime":"2025-02-04 23:02","pubTimestamp":1738681362,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日23时02分,Pulse Biosciences, Inc股票出现异动,股价急速拉升5.93%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体涨幅为0.05%。其相关个股中,Glucotrack, Inc.、Koru Medical Systems, Inc.、Pulse Biosciences, Inc涨幅较大,Glucotrack, Inc.、Sharps Technology Inc.、Avinger, Inc.较为活跃,换手率分别为227.32%、8.49%、2.10%,振幅较大的相关个股有Glucotrack, Inc.、Koru Medical Systems, Inc.、Predictive Oncology Inc.,振幅分别为68.41%、13.63%、6.27%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230242abc22e3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204230242abc22e3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507596439","title":"Pulse Biosciences, Inc盘中异动 早盘股价大涨5.19%报20.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507596439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507596439?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:37","pubTimestamp":1738337836,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时37分,Pulse Biosciences, Inc股票出现异动,股价快速上涨5.19%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体涨幅为0.21%。Pulse Biosciences, Inc公司简介:Pulse Biosciences Inc .是一家新型生物医药公司,致力于利用其获得专利的纳米脉冲刺激技术进行健康创新,这是一种革命性的能量模式,可提供纳秒持续时间的电能脉冲,每个脉冲的长度小于百万分之一秒,以非热清除的目标细胞,同时不影响邻近的非细胞组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131233716abbe47c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131233716abbe47c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507696542","title":"Pulse Biosciences, Inc盘中异动 下午盘大幅拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507696542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507696542?lang=zh_cn&edition=full","pubTime":"2025-01-29 02:28","pubTimestamp":1738088918,"startTime":"0","endTime":"0","summary":"北京时间2025年01月29日02时28分,Pulse Biosciences, Inc股票出现异动,股价急速拉升5.01%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体涨幅为0.56%。Pulse Biosciences, Inc公司简介:Pulse Biosciences Inc .是一家新型生物医药公司,致力于利用其获得专利的纳米脉冲刺激技术进行健康创新,这是一种革命性的能量模式,可提供纳秒持续时间的电能脉冲,每个脉冲的长度小于百万分之一秒,以非热清除的目标细胞,同时不影响邻近的非细胞组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012902283998758534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025012902283998758534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506895335","title":"Pulse Biosciences, Inc盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506895335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506895335?lang=zh_cn&edition=full","pubTime":"2025-01-25 01:18","pubTimestamp":1737739080,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日01时18分,Pulse Biosciences, Inc股票出现波动,股价大幅拉升5.05%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体跌幅为1.16%。Pulse Biosciences, Inc公司简介:Pulse Biosciences Inc .是一家新型生物医药公司,致力于利用其获得专利的纳米脉冲刺激技术进行健康创新,这是一种革命性的能量模式,可提供纳秒持续时间的电能脉冲,每个脉冲的长度小于百万分之一秒,以非热清除的目标细胞,同时不影响邻近的非细胞组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125011800a22e7d75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125011800a22e7d75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PLSE","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505102699","title":"Pulse Biosciences, Inc盘中异动 股价大跌5.18%报17.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505102699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505102699?lang=zh_cn&edition=full","pubTime":"2025-01-24 04:54","pubTimestamp":1737665683,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日04时54分,Pulse Biosciences, Inc股票出现波动,股价大幅下挫5.18%。Pulse Biosciences, Inc股票所在的医疗设备行业中,整体跌幅为0.19%。Pulse Biosciences, Inc公司简介:Pulse Biosciences Inc .是一家新型生物医药公司,致力于利用其获得专利的纳米脉冲刺激技术进行健康创新,这是一种革命性的能量模式,可提供纳秒持续时间的电能脉冲,每个脉冲的长度小于百万分之一秒,以非热清除的目标细胞,同时不影响邻近的非细胞组织。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124045444abb64491&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124045444abb64491&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","PLSE"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pulsebiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0621},{"period":"1month","weight":0.0481},{"period":"3month","weight":0.4328},{"period":"6month","weight":0.0833},{"period":"1year","weight":0.1825},{"period":"ytd","weight":0.4297}],"compareEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0787},{"period":"3month","weight":-0.0801},{"period":"6month","weight":-0.0546},{"period":"1year","weight":0.1373},{"period":"ytd","weight":-0.0732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"脉冲生物科学有限公司最初于2014年5月19日在内华达州注册成立。自2018年6月18日起,该公司重新注册为特拉华州公司。该公司是一家新型消融公司,致力于利用其专利的纳米脉冲刺激(“NPS”)技术进行健康创新,这是一种革命性的能量模式,可提供纳秒级持续时间的电能脉冲,每次脉冲长度不到百万分之一秒,以非热方式清除或杀死靶细胞。NPS技术,也称为纳秒脉冲场消融(“nsPFA”)技术,当用于消融细胞组织时,可用于治疗各种尚未找到最佳解决方案的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.7,"avgChangeRate":0.039406},{"month":2,"riseRate":0.4,"avgChangeRate":0.027622},{"month":3,"riseRate":0.4,"avgChangeRate":0.008717},{"month":4,"riseRate":0.555556,"avgChangeRate":0.123266},{"month":5,"riseRate":0.333333,"avgChangeRate":0.00138},{"month":6,"riseRate":0.5,"avgChangeRate":0.006609},{"month":7,"riseRate":0.5,"avgChangeRate":0.013289},{"month":8,"riseRate":0.6,"avgChangeRate":0.001957},{"month":9,"riseRate":0.5,"avgChangeRate":0.125621},{"month":10,"riseRate":0.3,"avgChangeRate":0.008129},{"month":11,"riseRate":0.5,"avgChangeRate":0.107856},{"month":12,"riseRate":0.6,"avgChangeRate":0.087874}],"exchange":"NASDAQ","name":"Pulse Biosciences, Inc.","nameEN":"Pulse Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pulse Biosciences, Inc.(PLSE)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Pulse Biosciences, Inc.(PLSE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Pulse Biosciences, Inc.,PLSE,Pulse Biosciences, Inc.股票,Pulse Biosciences, Inc.股票老虎,Pulse Biosciences, Inc.股票老虎国际,Pulse Biosciences, Inc.行情,Pulse Biosciences, Inc.股票行情,Pulse Biosciences, Inc.股价,Pulse Biosciences, Inc.股市,Pulse Biosciences, Inc.股票价格,Pulse Biosciences, Inc.股票交易,Pulse Biosciences, Inc.股票购买,Pulse Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pulse Biosciences, Inc.(PLSE)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Pulse Biosciences, Inc.(PLSE)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}